These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2821081)

  • 21. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dietary fiber on postprandial serum digoxin concentration in man.
    Kasper H; Zilly W; Fassl H; Fehle F
    Am J Clin Nutr; 1979 Dec; 32(12):2436-8. PubMed ID: 506966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of bran on digoxin absorption.
    Woods MN; Ingelfinger JA
    Clin Pharmacol Ther; 1979 Jul; 26(1):21-3. PubMed ID: 445958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.
    Tayrouz Y; Ding R; Burhenne J; Riedel KD; Weiss J; Hoppe-Tichy T; Haefeli WE; Mikus G
    Clin Pharmacol Ther; 2003 May; 73(5):397-405. PubMed ID: 12732840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin pharmacokinetics and spirapril, a new ace inhibitor.
    Johnson BF; Wilson J; Johnson J; Flemming J
    J Clin Pharmacol; 1991 Jun; 31(6):527-30. PubMed ID: 1880218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
    DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological availability of digoxin and beta-methyl-digoxin administered in the fasting state or after meals].
    Hess T; Krähenbühl A; Luisier J; Weiss M
    Schweiz Med Wochenschr; 1981 Sep; 111(39):1434-40. PubMed ID: 7291961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma digoxin concentrations during administration of dietary fibre (guar gum) in man.
    Lembcke B; Häsler K; Kramer P; Caspary WF; Creutzfeldt W
    Z Gastroenterol; 1982 Mar; 20(3):164-7. PubMed ID: 6282000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
    Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of tablet and capsule formulations of digoxin in the elderly.
    Hui J; Wang YM; Chandrasekaran A; Geraets DR; Caldwell JH; Robertson LW; Reuning RH
    Pharmacotherapy; 1994; 14(5):607-12. PubMed ID: 7997395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
    Verstuyft C; Strabach S; El-Morabet H; Kerb R; Brinkmann U; Dubert L; Jaillon P; Funck-Brentano C; Trugnan G; Becquemont L
    Clin Pharmacol Ther; 2003 Jan; 73(1):51-60. PubMed ID: 12545143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF; O'Grady J; Sabey GA; Bye C
    Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation: evaluation for sublingual and oral administrations in humans].
    Seo H; Uekama K
    Yakugaku Zasshi; 1989 Oct; 109(10):778-82. PubMed ID: 2621567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.